outbreak. Furthermore, it elaborates on patent-related policy options provided by the TRIPS Agreement, and WTO Members …COVID-19, caused by SARS-Cov-2, was declared to be a pandemic by the World Health Organization on 11 March 2020. Since … then, the issue of the relationship between patent protection and the development of and access to medical treatments and …

support national patent offices and interested parties in developing countries with information that can serve as guidance for … the examination of the claims contained in relevant patents or patent applications. The medicines considered for the … patent analysis in this report are remdesivir, ruxolitinib, favipiravir, molnupiravir and nirmatrelvir, and the …

The World Trade Organisation’s (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS … surveillance, tracking, diagnosis and treatment of COVID-19. A possible solution is a TRIPS waiver of the implementation …, application and enforcement for the prevention, containment or treatment of COVID-19. This comment addresses the ways that TRIPS …

-Related Aspect of Intellectual Property (TRIPS) flexibility? Is it right to grant the first generation of Covid-19 vaccines a special … the proliferation of immunity-escaping variants. Therefore governmental rationality around the world would suggest any … governments should bear the cost of the expected increased industry obsolescence determined by a temporary patent waiver; this …